Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Biognosys, Phenomenex

Premium

Biognosys has launched its new BloodSpotDive 100 multiple-reaction monitoring mass spec panel for dried blood spot analysis.

According to the company, the panel allows for routine quantification of 100 blood proteins directly from DBS samples. It is available as a fee-for-service product out of Biognosys' laboratory or for transfer to any lab equipped with a triple quadrupole mass spec.


Phenomenex has launched its 30 mm Kinetex core-shell 5-micron column for pharmaceutical lab-scale purifications.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.